TenderDekho Logo
GEM

Indian Air Force USFDA/DGCI Approved Third Generation Zotarolimus Drug Eluting Stent Tender 2026

Bid Publish Date

13-Jun-2026, 9:59 am

Bid End Date

23-Jun-2026, 11:00 am

Progress

Issue13-Jun-2026, 9:59 am
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

2

Bid Type

Two Packet Bid

Key Highlights

  • Brand/OEM authorization required for distributor bids
  • IS/II standards not specified; product must be USFDA/DGCI approved
  • 50% quantity option for up/down adjustments during contract
  • Shelf life requirement: minimum two years per DCGI/CDSCO; five-sixths remaining at supply
  • Invoice must be in consignee name with GSTIN
  • Data Sheet alignment mandatory; mismatches risk rejection
  • Non-toxic product requirement; MSDS if contains toxic materials
  • GST implications handled by bidder; reimbursement as actuals or as per rate
  • No BOQ items listed; emphasis on data sheet and OEM authorization

Categories 1

Tender Overview

The Indian Air Force procurement targets a USFDA/DGCI approved third generation Zotarolimus Drug Eluting Platinum/Cobalt Chromium coronary stent. No BOQ items are listed; however, the tender emphasizes data sheet verification, OEM authorization, and GST/PAN documentation. The contract contemplates a flexible quantity option of up to 50% and mandates adherence to shelf-life requirements aligned with DCGI/CDSCO guidelines. Location data is not provided in the notice, but this procurement clearly seeks biosafe, compliant cardiovascular stents suitable for high-spec defense medical use. Unique aspects include the explicit data sheet matching process and the requirement for manufacturer authorization when bidding through distributors.

Technical Specifications & Requirements

  • Product/Service: USFDA/DGCI approved third generation Zotarolimus drug-eluting stent (Platinum/Cobalt Chromium).
  • Documentation: Upload Data Sheet; PAN; GSTIN; Cancelled Cheque; EFT Mandate (bank-certified).
  • Authorization: OEM authorization form/certificate required if bidding through an authorized distributor.
  • Quality & Compliance: Data sheet must match offered product specifications; non-mio mismatch risks bid rejection.
  • Shelf Life: Minimum two years as per DCGI/CDSCO; at supply, at least five-sixths of shelf life remaining.
  • Invoicing: Invoice must name the consignee with their GSTIN.
  • Option Clause: Purchaser may increase/decrease quantity by up to 50% of bid quantity; delivery periods adjust accordingly.
  • Non-toxic: Product shall be non-toxic; provide MSDS if toxic materials involved.

Terms, Conditions & Eligibility

  • GST handling: Bidder bears GST impact; reimbursement as actuals or at applicable rates, capped to quoted GST percentage.
  • Submission for Vendor Code: Provide PAN, GSTIN, Cancelled Cheque, EFT Mandate.
  • Data Sheet Verification: Mandatory data sheet alignment with product specifications; mismatches can lead to rejection.
  • Manufacturer Authorization: Required when using an Authorized Distributor; furnish OEM details.
  • Delivery & Payment Terms: Option clause allows quantity adjustments; no fixed delivery window available in data.
  • Shelf Life Compliance: Minimum two-year shelf life; remaining shelf life criteria as per DCGI/CDSCO.
  • Invoicing Rule: Consignee GSTIN on the invoice.
  • Contractual Flexibility: No assignment or sub-contracting without buyer consent.

Key Specifications

    • Product/service: USFDA/DGCI approved third generation Zotarolimus drug-eluting stent (Platinum / cobalt chromium)
    • Shelf life: minimum two years per DCGI/CDSCO; minimum five-sixths remaining at supply
    • Invoicing: invoice in the name of consignee with consignee GSTIN
    • Authorization: OEM authorization required if bidding via authorized distributor
    • Quantity flexibility: up to 50% increase/decrease at contract placement and during currency
    • Documentation: upload Data Sheet; verify against product specifications

Terms & Conditions

  • EMD not specified (no amount provided in data); GST handling as per actuals or applicable rate

  • Data Sheet verification mandatory; mismatch leads to bid rejection

  • 50% quantity option and extended delivery time calculations apply

Important Clauses

Payment Terms

GST reimbursement to be as actuals or as per applicable rates, whichever is lower, up to quoted GST %

Delivery Schedule

Option to adjust quantity up to 50% at contract placement and during currency; delivery period alignment with last order date

Penalties/Liquidated Damages

Not specified in available data

Bidder Eligibility

  • Bidder must provide OEM authorization if bidding through an Authorized Distributor

  • Documents: PAN, GSTIN, Cancelled Cheque, EFT Mandate

  • Product data sheet must precisely match offered stent specifications

Additional Tender Data

Commercial Details

Tender Category

Goods

Bid To RA

No

Bid To RA Enabled

Yes

Item Category

USFDA/DGCI approved third generation Zotarolimus Drug Eluting Platinum / cobalt chromium coronary st

Authority Records

MINISTRY OF DEFENCEMILITARY AFFAIRS DEPARTMENT

BID & GeM Expert Consultancy

End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.

Bid Preparation GeM Registration Document Filing

Free consultation · 24h response

Documents 4

GeM-Bidding-9463757.pdf

Main Document

Other Documents

OTHER

Buyer uploaded ATC document

ATC

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Past Similar Tenders (Historical Results)

5 found

Dg Armed Forces Medical Service Coronary Stents Tender 2025 - Sirolimus/Everolimus Eluting Co-Cr, ISO Standards

Dg Armed Forces Medical Service

JAIPUR, RAJASTHAN

Posted: 3 November 2025
Closed: 17 November 2025
GEM

Coronary stent 3.0 mm 4th Generation Platinum Chromium Everolimus Eluting

Indian Army

PUNE, MAHARASHTRA

Posted: 27 September 2025
Closed: 18 October 2025
GEM

Indian Army Procurement: Dual Chamber Pacemaker MRI Compatible + 4th Gen Coronary Stent Supply in India 2025

Indian Army

PUNE, MAHARASHTRA

Posted: 14 January 2026
Closed: 24 January 2026
GEM

DRUG ELUTING CORONARY BALLOON SYSTEM

Indian Navy

MUMBAI, MAHARASHTRA

Posted: 3 February 2026
Closed: 24 February 2026
GEM

Indian Army Pune MS/MA Security Medical Equipment Tender 2025: Dual Chamber Pacemaker MRI-Compatible Stents & I-Lithotripsy Balloons ISO 9001

Indian Army

PUNE, MAHARASHTRA

Posted: 14 January 2026
Closed: 24 January 2026
GEM

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Required Documents

1

Copy of PAN Card

2

Copy of GSTIN

3

Copy of Cancelled Cheque

4

Copy of EFT Mandate certified by Bank

5

Data Sheet of offered product

6

Manufacturer Authorization / OEM authorization form with distributor details

Frequently Asked Questions

How to bid for Indian Air Force medical stent tender in 2026 with OEM authorization

Bidders must provide OEM authorization if bidding through a distributor, plus PAN, GSTIN, cancelled cheque, and EFT mandate. Upload the product’s Data Sheet, ensure it matches offered specifications, and adhere to shelf-life requirements per DCGI/CDSCO. Ensure GST handling aligns with actuals or quoted rates.

What documents are required for the Zotarolimus stent tender in Delhi

Required documents include PAN Card, GSTIN, Cancelled Cheque, EFT Mandate certified by bank, and Data Sheet of the offered stent. If bidding via an Authorized Distributor, include Manufacturer Authorization with OEM details. Ensure the invoice is raised in the consignee's name with their GSTIN.

What are the technical specifications for USFDA DGCI stent in this bid

Specifications demand a third generation Zotarolimus drug-eluting stent made of Platinum/Cobalt Chromium with USFDA and DGCI approvals. Data Sheet must precisely reflect the product. Shelf-life minimum two years per DCGI/CDSCO; at supply, five-sixths of shelf life should remain.

What is the quantity adjustment allowed under the option clause for this tender

The purchaser may alter bid quantity by up to 50% at contract placement and during the currency. Additional delivery time is calculated as (increased quantity/original quantity) × original delivery period, with a minimum of 30 days and subject to contract terms.

When is GST reimbursement implemented for this medical device tender in India

GST reimbursement is provided as actuals or at the applicable rate, whichever is lower, constrained to the quoted GST percentage. Bidders must track GST rules and ensure invoicing aligns with the consignee’s GSTIN to qualify for reimbursement.

What are the invoicing requirements for the consignee in this procurement

Invoices must be raised in the name of the consignee with the consignee's GSTIN. This ensures proper GST credit and compliance. Cross-check GSTIN accuracy in the vendor code and ensure data sheets align with the invoiced product.

What is the shelf-life requirement for stents under this bid in India

Stents must have a minimum two-year shelf life per DCGI/CDSCO guidelines, with at least five-sixths of the shelf life remaining at the time of supply. Non-compliance leads to rejection or post-award corrective actions.

Similar Tenders

5 found
Urgent

Indian Air Force USFDA/DGCI Approved Everolimus Drug-Eluting Third Generation Platinum-Chromium Coronary Stent Tender 2026

Indian Air Force

⏰ Deadline: 5 days left
🛒 Type: Goods
View GEM
Urgent

Indian Air Force Medicines Tender 2026 for Sirolimus Eluting DES CoCr Platform with ISO 9001 2026

Indian Air Force

Est: ₹80,356.5
⏰ Deadline: 5 days left
🛒 Type: Goods
View GEM
Urgent

013403_Permanent Pacemaker DDDR_ Complete with temporary pacing lead,013404_Permanent Pacemaker VVI

Indian Air Force

📍 BANGALORE, KARNATAKA

EMD: ₹2.0 L
Est: ₹4.0 Cr
⏰ Deadline: 2 days left
🛒 Type: Goods
View GEM
Urgent

Tab zongertinib 60 mg

Indian Army

📍 CENTRAL DELHI, DELHI

⏰ Deadline: 2 days left
🛒 Type: Goods
View GEM
Urgent

Yantra India Limited Zinc Ingot Tender Thane Maharashtra IS:209 1992 99.95% 2026

Yantra India Limited

📍 THANE, MAHARASHTRA

EMD: ₹56.9 L
⏰ Deadline: 7 days left
🛒 Type: Goods
View GEM

Explore More Opportunities

Quick Access